Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826457 · ClinicalTrials.gov registry record
North American Prodromal Synucleinopathy Consortium Stage 2
A clinical trial of Parkinson Disease and Multiple System Atrophy, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 500
- Enrollment target
- 9
- Study locations
NCT05826457 is a study of Parkinson Disease and Multiple System Atrophy that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 500 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The trial reports 9 study locations across 7 states.
The verdict
NCT05826457, a study of Parkinson Disease and Multiple System Atrophy, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Conditions Studied
Study Locations (9)
California
- University of California Los Angeles - Los Angeles
- Stanford University - Redwood City
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic Rochester - Rochester
Georgia
- Emory University - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Missouri
- Washington University School of Medicine - St Louis
Oregon
- Oregon Health Sciences University - Portland
Quebec
- McGill University Health Centre Research Institute - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-08-12 |
| Est. Completion | 2025-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05826457
The ClinicalTrials.gov registry entry for NCT05826457 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05826457 reports 9 study locations spanning 7 distinct geographic areas - top geographies include California, Minnesota, Georgia.
Frequently Asked Questions
What is clinical trial NCT05826457 about?
NCT05826457 is a clinical study titled "North American Prodromal Synucleinopathy Consortium Stage 2". This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
What is the current status of trial NCT05826457?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-08-12. Estimated completion is 2025-05-01.
What conditions does trial NCT05826457 study?
This clinical trial studies the following conditions: Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies, REM Sleep Behavior Disorder, Lewy Body Dementia.
Who is sponsoring clinical trial NCT05826457?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05826457 being conducted?
This trial has 9 study locations across California, Georgia, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.